학술논문
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
Document Type
Article
Author
Source
In Annals of Oncology August 2015 26(8):1741-1748
Subject
Language
ISSN
0923-7534